CanGaroo® Registry Study

NCT04846127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-05-15

No results posted yet for this study

Summary

A Multi-Center Registry Evaluating Participants Who Receive CanGaroo Envelope or No Envelope During their CIED Implantation

Conditions

  • Arrhythmias, Cardiac

Interventions

DEVICE

CanGaroo Envelope

Utilization of a CanGaroo envelope with the CIED during the participant's CIED implant procedure.

Sponsors & Collaborators

  • Elutia Inc.

    lead INDUSTRY

Principal Investigators

  • Thomas F. Deering, MD · Piedmont Heart Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-25
Primary Completion
2023-04-17
Completion
2024-10-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04846127 on ClinicalTrials.gov